China Universal Asset Management Co., Ltd. Arcutis Biotherapeutics, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $893 Million
- Q3 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 22,482 shares of ARQT stock, worth $223,246. This represents 0.02% of its overall portfolio holdings.
Number of Shares
22,482
Previous 13,601
65.3%
Holding current value
$223,246
Previous $126,000
65.87%
% of portfolio
0.02%
Previous 0.02%
Shares
14 transactions
Others Institutions Holding ARQT
# of Institutions
197Shares Held
129MCall Options Held
738KPut Options Held
82K-
Jennison Associates LLC11.7MShares$116 Million0.07% of portfolio
-
Rubric Capital Management LP New York, NY11MShares$109 Million2.84% of portfolio
-
Suvretta Capital Management, LLC New York, NY10.7MShares$106 Million3.92% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.79MShares$87.2 Million4.4% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$85.6 Million0.0% of portfolio
About Arcutis Biotherapeutics, Inc.
- Ticker ARQT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,187,500
- Market Cap $598M
- Description
- Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...